Miranda

Bristol Myers Squibb (BMS) announced this week (August 10, 2026) the selection of Houston, Texas, as the site for a new $2.3-billion, 600,000-square-foot multi-modal manufacturing campus as part of the…

Novo Nordisk and Amazon Web Services (AWS) have formed a strategic partnership to accelerate drug discovery and modernize Novo Nordisk’s operations through agentic AI and cloud technologies. As part of…

To boost its rare-disease drug portfolio, Jazz Pharmaceuticals, a Dublin, Ireland-based bio/pharmaceutical company, has agreed to acquire Actio Biosciences, a San Diego, California-based clinical-stage bio/pharmaceutical company developing small molecules for…

The latest from CDMOs, CMOs, and suppliers featuring  CordenPharma, Cambrex, Thermo Fisher, LTS Lohmann Therapie-Systeme, Polpharma API, and Pace.  Chemicals/Chemical API Manufacturing * CordenPharma Completes Acquisition of Peptide CDMO AmbioPharm* Cambrex…

A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Eli Lilly and Company, Takeda, Moderna, Sobi, Zealand Pharma, and Zydus Life Sciences. Highlights below.  For the latest…

The latest from small and Emerging Pharma companies featuring Tarsus Pharmaceuticals. For news on the large and mid-sized bio/pharmaceutical companies, see Global Briefs. *Tarsus Pharmaceuticals To Acquire Alkeus Pharma in…

Novartis has announced plans to expand its operations in North Carolina by creating a new manufacturing hub with drug-substance and drug-product capabilities. The investment is part of the company’s previously…

Regeneron Pharmaceuticals, a Tarrytown, New York-based bio/pharmaceutical company, has announced plans to invest $2 billion for a new manufacturing facility in Saratoga Springs, New York.   The company plans to use…